Preferential inhibition of tumors by drug depressing DNA polymerases.
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000494:pharmacology*; D004254:DNA Nucleotidyltransferases / Q000037:antagonists & inhibitors*; D006801:Humans; D008099:Liver / Q000201:enzymology; D008115:Liver Regeneration; D009369:Neoplasms / Q000188:drug therapy* / Q000201:enzymology; D051381:Rats; D013438:Sulfhydryl Compounds / Q000037:antagonists & inhibitors; D013439:Sulfhydryl Reagents / Q000494:pharmacology* / Q000627:therapeutic use
D000970:Antineoplastic Agents; D013438:Sulfhydryl Compounds; D013439:Sulfhydryl Reagents; D004254:DNA Nucleotidyltransferases